5International Program for Chemical Safety. Environment Health Criteria 118: Inorganic Mercury. Geneva, WHO, 1991.
6Olsson S, Bergman M. Daily dose calculations from measurement of intra-oral mercury vapour. J Dent Res, 1992,71: 414
7Kingman A, Albertini T,Brown L, et al. Mercury concentrations in whole blood associated with amalgam expouse in a US military population. J Dent Res, 1998,77:461
8Mortada WI,Sobh MA, EI-Defrawy MM, et al. Mercury in dental restoration: Is there a risk of nephrotoxicity? J Nephrol, 2002,15:171
9Price RG. Urinalysis to exclude and monitor nephrotoxicity. Clin Chim Acta, 2000,297:173
10Thompson CM, Markesbery WR, Ehmannm WD. Regional brain trace- element studies in Alzheimer's disease. Neurotoxicology,1988,9:1
5Valeyrie-Allanore L, Sassolas B, Roujeau J C. Drug-induced skin, nail and hair disorders[J]. Drug Saf, 2007,30 (11) : 1011- 1130.
6Reiner Z, Catapano A L, de Backer G, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)[J]. Eur Heart J,2011,32(14):1769-1818.
7Hennecke J. Allergie und Schwingung [M]. Stolberg: Astro- Spiegel-Verlag Stolberg, 2002 : 201-203.
8Heinzerling L M, Tomsitz D, Anliker M D. Is drug allergy less prevalent than previously assumed: a 5-year analysis[J]. Br J Dermatol, 2012,166(1) : 107-114.
9Shear N H, Milpied B, Bruynzeel D P, etal. A review of drug patch testing and implications for HIV elinieians[J]. AIDS, 2008,22 (9) : 999-1007.
10Messaad D, Sahla H, Benahmed S, et al. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction[J]. Ann Intern Med, 2004,140 (12):1001-1006.
